Obesity is a significant global health burden with increasing prevalence.
Considered a potentially heritable trait.
Monogenic obesity is linked to defects in hypothalamic circuits regulating appetite and energy homeostasis, such as leptin mutations which lead to uncontrolled eating.
Common obesity tends to arise from interactions among genetic, epigenetic, and environmental factors.
Monogenic obesity can be:
Syndromic: Associated with other traits (e.g., cognitive impairments).
Non-syndromic: Not associated with other conditions; often linked to specific genes like MC4R, LEP, LEPR, PCSK1.
79 syndromes identified, with some fully or partially characterized genetically.
Prader-Willi Syndrome: Chromosomal imprinting defect.
Bardet-Biedl Syndrome: Linked to 19 different genes.
Homozygous mutations in leptin-related genes can lead to severe obesity, often requiring treatment with recombinant leptin.
Most individuals suffer from common (multifactorial) obesity due to interactions among numerous genetic loci, with minor effects on BMI.
GWAS (Genome-wide Association Studies) have identified over 870 SNPs related to obesity but explain only 5% of BMI variance.
Major contributors include genes affecting appetite regulation, insulin action, and lipid metabolism.
Genetic factors have considerable interactions with environmental influences, particularly lifestyle and dietary choices.
Studies show that physical activity can reduce the impact of genetic predispositions, especially related to the FTO gene.
Dietary habits also significantly modulate how genetic variants influence obesity risk.
Epigenetic changes (e.g., DNA methylation) modify gene expression without altering DNA sequences.
DNA Methylation in Obesity:
Recent studies focus on the correlation of DNA methylation changes with obesity traits.
Certain methylation patterns in genes associated with metabolism correlate with BMI and metabolic syndrome markers.
Important studies identify specific genes whose methylation levels correlate with BMI.
HIF3A found to have significant methylation related to higher BMI across diverse tissues.
Behavioral interventions such as exercise and weight loss (e.g., bariatric surgery) lead to notable changes in DNA methylation patterns.
Exercise and dietary modifications can improve metabolic outcomes and influence gene expression in adipose tissue.
Efforts to implement precision medicine strategies that tailor interventions based on genetic and epigenetic profiles are ongoing.
There is potential for personalized management strategies for monogenic obesity through genetic testing; however, common obesity presents more varied responses to treatment based on individualized risk profiles.
The complexity of obesity's etiology necessitates continued research into genetic and epigenetic interactions with lifestyle factors.
Understanding these dynamics may lead to improved prevention and treatment strategies.